Clusters of basic amino acids in midkine: roles in neurite-promoting activity and plasminogen activator-enhancing activity

J Biochem. 1998 Jun;123(6):1127-36. doi: 10.1093/oxfordjournals.jbchem.a022052.

Abstract

The removal of N-terminally located clusters of basic amino acids (N-tail) or C-terminally located clusters of basic amino acids (C-tail) from the midkine (MK) molecule severely reduced its neurite-promoting activity. However, experiments involving chemically synthesized MK derivatives revealed that the roles of the N-tail and C-tail were mostly indirect ones, i.e. they probably maintain the steric arrangements of the N-terminal and C-terminal halves. In particular, the C-domain, which is the C-terminal half devoid of the C-tail, retained considerable neurite-promoting activity when it was uniformly coated on a dish. The removal of the N-tail or C-tail also reduced the enhancing activity of plasminogen activator (PA) in aortic endothelial cells, although the effect was lower. There are two heparin-binding sites in the C-domain, Clusters I and II. A mutation in Cluster I [R78-->Q] affected the PA-enhancing activity only slightly, and a mutation in Cluster II [K83K84-->QQ] abolished the activity, while both mutations are known to reduce the neurite-promoting activity moderately. Therefore, the two heparin-binding sites in the C-domain play different roles in these two activities. Indeed, heparin exhibited different effects on these two activities. We also observed that intact MK was required for ordered neurite-promotion along the path of MK; one possible interpretation of this is that the N-terminal half is necessary for the stability of the molecule. Furthermore, K76 and K99 were found to be required for the secretion of MK; i.e. mutants in which one of these K residues was changed to Q were produced in the host cells, but not found in the medium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Amino Acids / genetics
  • Animals
  • Carrier Proteins / genetics*
  • Carrier Proteins / metabolism
  • Carrier Proteins / pharmacology*
  • Cells, Cultured
  • Cytokines*
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Humans
  • Mice
  • Midkine
  • Mutation
  • Nerve Growth Factors / genetics*
  • Nerve Growth Factors / metabolism
  • Nerve Growth Factors / pharmacology*
  • Neurites / drug effects
  • Neurites / ultrastructure
  • Plasminogen / drug effects
  • Plasminogen / metabolism*
  • Plasminogen Activators / genetics*
  • Plasminogen Activators / metabolism
  • Plasminogen Activators / pharmacology*

Substances

  • Amino Acids
  • Carrier Proteins
  • Cytokines
  • Nerve Growth Factors
  • Midkine
  • Plasminogen
  • Plasminogen Activators